Studies have revealed that chemotherapy-induced neutrophil extracellular traps (NETs) capture tumor-derived TGF-β via integrin αvβ1 and activate this factor using MMP-9, further promoting the EMT process, thereby reducing the chemotherapy efficacy against breast cancer lung metastasis (73). The gene discussed is MMP9; the disease is breast carcinoma.